March 6, 2009 (Munich, Germany) — More evidence that patients with a low platelet responsiveness to clopidogrel have an increased risk of stent thrombosis has come from a new study, with the ...

December 4, 2009 (Munich, Germany) - Patients undergoing PCI who had an enhanced response to clopidogrel as assessed by a platelet-function test had three times the risk of major bleeding compared ...

Federal drug regulators added a boxed warning to the anti-blood clotting medicine Plavix, alerting physicians and patients that it could be less effective in people who cannot metabolize the pill ...

The somewhat conflicting results of CURRENT-OASIS 7 have inspired new correspondence in the January 22, 2011, issue of the Lancet that question how best to implement the study’s findings regarding ...

ORLANDO -- The widely used herbal remedy St. John's wort appears to amplify the action of the popular blood-thinning drug clopidogrel, sold as Plavix, a small new clinical study finds. The effect ...

Researchers have identified a common gene variant carried by as many as a third of the general population that is believed to play a major role in determining why people do not respond to a popular ...